Review



recombinant galectin 1  (Galectin Therapeutics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Galectin Therapeutics recombinant galectin 1
    Recombinant Galectin 1, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant galectin 1/product/Galectin Therapeutics
    Average 86 stars, based on 1 article reviews
    recombinant galectin 1 - by Bioz Stars, 2026-06
    86/100 stars

    Images



    Similar Products

    recombinant mouse gal  (Sino Biological)
    92
    Sino Biological recombinant mouse gal
    Recombinant Mouse Gal, supplied by Sino Biological, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse gal/product/Sino Biological
    Average 92 stars, based on 1 article reviews
    recombinant mouse gal - by Bioz Stars, 2026-06
    92/100 stars
    		  Buy from Supplier
    galectin 7 concentrations  (Boster Bio)
    94
    Boster Bio galectin 7 concentrations
    Distributions of osteopontin <t>and</t> <t>galectin-7</t> in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).
    Galectin 7 Concentrations, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/galectin 7 concentrations/product/Boster Bio
    Average 94 stars, based on 1 article reviews
    galectin 7 concentrations - by Bioz Stars, 2026-06
    94/100 stars
    		  Buy from Supplier
    osteopontin  (Boster Bio)
    94
    Boster Bio osteopontin
    Distributions of <t>osteopontin</t> and galectin-7 in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).
    Osteopontin, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/osteopontin/product/Boster Bio
    Average 94 stars, based on 1 article reviews
    osteopontin - by Bioz Stars, 2026-06
    94/100 stars
    		  Buy from Supplier
    recombinant human rh gal 1  (R&D Systems)
    94
    R&D Systems recombinant human rh gal 1
    Distributions of <t>osteopontin</t> and galectin-7 in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).
    Recombinant Human Rh Gal 1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human rh gal 1/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    recombinant human rh gal 1 - by Bioz Stars, 2026-06
    94/100 stars
    		  Buy from Supplier
    recombinant galectin 1  (Galectin Therapeutics)
    86
    Galectin Therapeutics recombinant galectin 1
    Distributions of <t>osteopontin</t> and galectin-7 in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).
    Recombinant Galectin 1, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant galectin 1/product/Galectin Therapeutics
    Average 86 stars, based on 1 article reviews
    recombinant galectin 1 - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier
    recombinant human lectin mgl fc  (Sino Biological)
    91
    Sino Biological recombinant human lectin mgl fc
    Distributions of <t>osteopontin</t> and galectin-7 in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).
    Recombinant Human Lectin Mgl Fc, supplied by Sino Biological, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human lectin mgl fc/product/Sino Biological
    Average 91 stars, based on 1 article reviews
    recombinant human lectin mgl fc - by Bioz Stars, 2026-06
    91/100 stars
    		  Buy from Supplier
    recombinant galectin-1  (Galectin Therapeutics)
    90
    Galectin Therapeutics recombinant galectin-1
    Distributions of <t>osteopontin</t> and galectin-7 in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).
    Recombinant Galectin 1, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant galectin-1/product/Galectin Therapeutics
    Average 90 stars, based on 1 article reviews
    recombinant galectin-1 - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Distributions of osteopontin and galectin-7 in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).

    Journal: Journal of Clinical Medicine

    Article Title: The Impact of Osteopontin and Galectin-7 on the Preoperative Diagnosis of Ovarian Tumors: A Case–Control Study

    doi: 10.3390/jcm15062178

    Figure Lengend Snippet: Distributions of osteopontin and galectin-7 in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).

    Article Snippet: Osteopontin and galectin-7 concentrations were quantified from serum using commercially available ELISA kits by Boster Biological Technology (Pleasanton, CA, USA).

    Techniques:

    Galectin-7 levels in relation to age.

    Journal: Journal of Clinical Medicine

    Article Title: The Impact of Osteopontin and Galectin-7 on the Preoperative Diagnosis of Ovarian Tumors: A Case–Control Study

    doi: 10.3390/jcm15062178

    Figure Lengend Snippet: Galectin-7 levels in relation to age.

    Article Snippet: Osteopontin and galectin-7 concentrations were quantified from serum using commercially available ELISA kits by Boster Biological Technology (Pleasanton, CA, USA).

    Techniques:

    Receiver operating characteristic (ROC) curves for osteopontin and galectin-7.

    Journal: Journal of Clinical Medicine

    Article Title: The Impact of Osteopontin and Galectin-7 on the Preoperative Diagnosis of Ovarian Tumors: A Case–Control Study

    doi: 10.3390/jcm15062178

    Figure Lengend Snippet: Receiver operating characteristic (ROC) curves for osteopontin and galectin-7.

    Article Snippet: Osteopontin and galectin-7 concentrations were quantified from serum using commercially available ELISA kits by Boster Biological Technology (Pleasanton, CA, USA).

    Techniques:

    Receiver operating characteristic (ROC) curves for osteopontin (blue), galectin-7 (red), and the combined logistic regression model (green) in discriminating malignant from benign ovarian tumors.

    Journal: Journal of Clinical Medicine

    Article Title: The Impact of Osteopontin and Galectin-7 on the Preoperative Diagnosis of Ovarian Tumors: A Case–Control Study

    doi: 10.3390/jcm15062178

    Figure Lengend Snippet: Receiver operating characteristic (ROC) curves for osteopontin (blue), galectin-7 (red), and the combined logistic regression model (green) in discriminating malignant from benign ovarian tumors.

    Article Snippet: Osteopontin and galectin-7 concentrations were quantified from serum using commercially available ELISA kits by Boster Biological Technology (Pleasanton, CA, USA).

    Techniques:

    Distributions of osteopontin and galectin-7 in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).

    Journal: Journal of Clinical Medicine

    Article Title: The Impact of Osteopontin and Galectin-7 on the Preoperative Diagnosis of Ovarian Tumors: A Case–Control Study

    doi: 10.3390/jcm15062178

    Figure Lengend Snippet: Distributions of osteopontin and galectin-7 in controls (normal) vs. cases (benign and malignant). No statistically significant differences were observed between groups for osteopontin ( p = 0.562) or galectin-7 ( p = 0.138).

    Article Snippet: Osteopontin and galectin-7 concentrations were quantified from serum using commercially available ELISA kits by Boster Biological Technology (Pleasanton, CA, USA).

    Techniques:

    Receiver operating characteristic (ROC) curves for osteopontin and galectin-7.

    Journal: Journal of Clinical Medicine

    Article Title: The Impact of Osteopontin and Galectin-7 on the Preoperative Diagnosis of Ovarian Tumors: A Case–Control Study

    doi: 10.3390/jcm15062178

    Figure Lengend Snippet: Receiver operating characteristic (ROC) curves for osteopontin and galectin-7.

    Article Snippet: Osteopontin and galectin-7 concentrations were quantified from serum using commercially available ELISA kits by Boster Biological Technology (Pleasanton, CA, USA).

    Techniques:

    Receiver operating characteristic (ROC) curves for osteopontin (blue), galectin-7 (red), and the combined logistic regression model (green) in discriminating malignant from benign ovarian tumors.

    Journal: Journal of Clinical Medicine

    Article Title: The Impact of Osteopontin and Galectin-7 on the Preoperative Diagnosis of Ovarian Tumors: A Case–Control Study

    doi: 10.3390/jcm15062178

    Figure Lengend Snippet: Receiver operating characteristic (ROC) curves for osteopontin (blue), galectin-7 (red), and the combined logistic regression model (green) in discriminating malignant from benign ovarian tumors.

    Article Snippet: Osteopontin and galectin-7 concentrations were quantified from serum using commercially available ELISA kits by Boster Biological Technology (Pleasanton, CA, USA).

    Techniques: